Literature DB >> 16169718

Two classes of p38alpha MAP kinase inhibitors having a common diphenylether core but exhibiting divergent binding modes.

Enrique L Michelotti1, Kristofer K Moffett, Duyan Nguyen, Martha J Kelly, Rupa Shetty, Xiaomei Chai, Katrina Northrop, Variketta Namboodiri, Brandon Campbell, Gary A Flynn, Ted Fujimoto, Frank P Hollinger, Marina Bukhtiyarova, Eric B Springman, Michael Karpusas.   

Abstract

Two new classes of diphenylether inhibitors of p38alpha MAP kinase are described. Both chemical classes are based on a common diphenylether core that is identified by simulated fragment annealing as one of the most favored chemotypes within a prominent hydrophobic pocket of the p38alpha ATP-binding site. In the fully elaborated molecules, the diphenylether moiety acts as an anchor occupying the deep pocket, while polar extensions make specific interactions with either the adenine binding site or the phosphate binding site of ATP. The synthesis, crystallographic analysis, and biological activity of these p38alpha inhibitors are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169718     DOI: 10.1016/j.bmcl.2005.08.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK.

Authors:  Natalie B Vinh; Jamie S Simpson; Peter J Scammells; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2012-04-20       Impact factor: 3.686

2.  Fluorophore labeled kinase detects ligands that bind within the MAPK insert of p38α kinase.

Authors:  Matthäus Getlik; Jeffrey R Simard; Martin Termathe; Christian Grütter; Matthias Rabiller; Willem A L van Otterlo; Daniel Rauh
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

3.  Understanding the Multitarget Pharmacological Mechanism of the Traditional Mongolian Common Herb Pair GuangZao-RouDouKou Acting on Coronary Heart Disease Based on a Bioinformatics Approach.

Authors:  Jingkun Lu; Yuchong Hu; Lechun Wang; Yuewu Wang; Shengsang Na; Jian Wang; Yuhui Shun; Xiaoqin Wang; Peifeng Xue; Pengwei Zhao; Liping Su
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-11       Impact factor: 2.629

4.  Multi-stage virtual screening of natural products against p38α mitogen-activated protein kinase: predictive modeling by machine learning, docking study and molecular dynamics simulation.

Authors:  Ruoqi Yang; Xuan Zha; Xingyi Gao; Kangmin Wang; Bin Cheng; Bin Yan
Journal:  Heliyon       Date:  2022-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.